Neutral impactCorporate Action
Jagsonpal Pharmaceuticals Limited — Updates
NSE 15 Jul·15 Jul 2026, 11:03 am
Jagsonpal Pharmaceuticals'Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 94,000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 ( JPL ESOP 2022 )'.
Affected stocks
Neutral1 stockBull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Jagsonpal Pharmaceuticals (JAGSNPHARM).
- Category: Corporate Action.
Why it matters
A routine update for Jagsonpal Pharmaceuticals. Use the price and stock snapshot to gauge how the market is responding.
